文献速递产科母胎医学生殖医学

供卵妊娠高血压并发症风险的个体参与者数据荟萃分析

The risk for the development of hypertensive complications in oocyte donation pregnancy: a systematic review and individual participant data meta-analysis (DONOR IPD).
PubMed 文献 · Hum Reprod Update · 2026-01-01

该研究通过个体参与者数据荟萃分析,比较供卵妊娠与自体妊娠(自然妊娠或IVF/ICSI)的高血压并发症风险。调整混杂因素后,供卵妊娠高血压并发症、子痫前期风险显著升高,且不受多数亚组因素影响。

要点

  • 供卵妊娠高血压并发症风险显著高于自体妊娠,调整后OR约2.6-2.9。
  • 风险升高不受年龄、BMI、多胎、产次等因素影响,需提高警惕。

核心结论

  • 供卵妊娠较自体妊娠高血压并发症风险显著增加,包括妊娠期高血压和子痫前期。

研究设计与样本

  • 系统综述与个体参与者数据荟萃分析,检索PubMed、EMBASE和Cochrane至2024年3月,最后更新2025年2月。
  • 纳入观察性研究,比较>20周供卵妊娠与自体妊娠(自然或IVF/ICSI),共16个队列提供IPD。

主要发现

  • 供卵 vs 自体妊娠高血压并发症总调整OR:一阶段2.62(95%CI 2.22-3.10),两阶段2.85(95%CI 2.30-3.54;I²=44%;中等确定性)。
  • 妊娠期高血压调整OR:一阶段2.15(95%CI 1.73-2.68),两阶段1.49(95%CI 0.80-2.80;I²=74%;低确定性)。
  • 子痫前期调整OR:一阶段2.28(95%CI 1.88-2.78),两阶段2.39(95%CI 1.94-2.94;I²=0%;高确定性)。
  • HELLP综合征风险在供卵妊娠中更高,但95%CI较宽。
  • 亚组分析显示风险升高不受母亲年龄、BMI、多胎、产次、种族、病史和移植胚胎数影响。

关键数值与推荐

  • 供卵妊娠高血压并发症总风险调整OR约2.62-2.85(中等确定性)。
  • 子痫前期风险调整OR约2.28-2.39(高确定性)。
  • 妊娠期高血压风险调整OR约1.49-2.15(低确定性)。
  • 使用乙酰水杨酸或肝素可能降低高血压并发症风险,但需更多证据确认。

临床怎么用

  • 应提高对供卵妊娠高血压并发症风险的警惕,加强产前监测。
  • 国际产科指南可参考本IPD荟萃分析结果制定供卵妊娠管理建议。
  • 低剂量乙酰水杨酸预防治疗可能有益,但需进一步验证。

局限性

  • 妊娠期高血压结果异质性较高(I²=74%),证据确定性低。
  • HELLP综合征结果95%CI较宽,精确性有限。
  • 仅16个队列提供IPD,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oocyte donation (OD) is an established ART involving an oocyte donor and recipient with a rising number of treatments. Previous meta-analyses highlight increased risks of hypertensive complications compared to naturally conceived (NC) and IVF/ICSI pregnancies, including pregnancy-induced hypertension (PIH) and preeclampsia (PE), but limitations exist due to study quality and heterogeneity. OBJECTIVE AND RATIONALE: The DONOR (DONation of Oocytes in Reproduction) individual participant data (IPD) meta-analysis aims to generate clinically relevant and robust evidence regarding the development of hypertensive complications in OD pregnancies compared to autologous pregnancies. IPD meta-analyses offer an advantage over current meta-analyses, as bias is reduced by using IPD of original studies, allowing reliability checks, correction for confounders, and examining causes of heterogeneity by subgroup analyses. Furthermore, using IPD increases statistical power and generalizability of results. SEARCH METHODS: A literature search was conducted using PubMed, EMBASE, and Cochrane up to March 2024, with a last update performed in February 2025. We included observational studies that compared a cohort of women pregnant after OD beyond 20 weeks of gestation with an autologous pregnancy cohort (NC or IVF/ICSI), and reported on hypertensive pregnancy complications. Risk of bias was assessed using the ROBINS-I tool. Authors of eligible articles were invited to share IPD. The DONOR IPD meta-analyses were executed using both a one- and two-stage approach, adjusted for maternal age, parity, and multiple gestation. Furthermore, sensitivity, meta-regression and subgroup analysis were performed. OUTCOMES: IPD was requested for 48 cohorts, and provided from 16 cohorts with data of 2747 OD, 4699 IVF/ICSI, and 33 323 NC pregnancies. The one- and two-stage approach comparing OD to autologous pregnancies showed adjusted ORs of respectively 2.62 (95% CI 2.22-3.10) and 2.85 (95% CI 2.30-3.54; I2 44%; moderate certainty) for hypertensive complications in total, 2.15 (95% CI 1.73-2.68) and 1.49 (95% CI 0.80-2.80; I2 74%; low certainty) for PIH, and 2.28 (95% CI 1.88-2.78) and 2.39 (95% CI 1.94-2.94; I2 0%; high certainty) for PE. When the autologous group was split into NC and IVF/ICSI pregnancies, higher risks for hypertensive complications, including PIH and PE, persisted in the OD group. The results of the IPD meta-analyses for HELLP syndrome show a higher risk in OD pregnancy, though with a broad 95% CI. Sensitivity meta-analyses for risk of bias showed comparable results. Subgroup analyses indicated increased risks for hypertensive complications in OD pregnancy, regardless of maternal age, BMI, multiple pregnancy, parity, ethnicity, medical history, and number of transferred embryos. A potential lower risk for hypertensive complications was found when acetylsalicylic acid or heparin is used during OD pregnancy compared to both autologous and NC pregnancy. WIDER IMPLICATIONS: The DONOR IPD meta-analysis provided a unique opportunity to assess the risk for hypertensive complications in OD compared to autologous pregnancy. The results must increase alertness of health care professionals who are involved in OD health care towards the risk profile of these pregnancies, as the DONOR IPD meta-analysis results in the best evidence-based statement for international guidelines in obstetrics to date. Possibly, preventive treatment with low-dose acetylsalicylic acid is successful in lowering the risk for hypertensive complications, though more evidence is needed to confirm this effect, alongside the underlying pathological mechanism. REGISTRATION NUMBER: CRD42021267908.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. van Bentem K, van der Hoorn ML, Banker M, et al. The risk for the development of hypertensive complications in oocyte donation pregnancy: a systematic review and individual participant data meta-analysis (DONOR IPD). Hum Reprod Update. 2026. PMID: 41915703. doi:10.1093/humupd/dmag006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。